Skip to main content
. Author manuscript; available in PMC: 2021 May 15.
Published in final edited form as: Cancer. 2020 May 15;126(Suppl 10):2353–2364. doi: 10.1002/cncr.32871

Table 1.

Summary of selected support systems for low- and middle-income countries

Resource level Cancer plan Coverage of financing for cancer care Platform for breast cancer program Essential Medicines List
Basic Cancer included in NCD plan, e.g. Mozambique prior to 2019 Payment largely out-of-pocket Cancer care focuses mainly on cervical cancer Includes basic cancer medicines
Core Separate cancer plan; e.g. Ghana plan 2012–2016 with one paragraph on breast cancer; Zambia 2016–2021 with two paragraphs on breast cancer Selected cancers covered by growing national insurance, e.g. Ghana covers basic breast & cervical cancers treatment Breast cancer care added onto cervical cancer platform (e.g. Zambia); or onto reproductive health platform (e.g. India pilot) in low income states Includes basic cancer medicines and some may be publicly subsidized; includes basic hormonal therapies (e.g. Ghana)
Enhanced Cancer plan articulated to include cancer-specific goals, e.g. Malaysia’s 2016–2020 plan with several pages specifically on breast cancer resources Broader coverage of cancer types overall in NHI; broader coverage of breast cancer stages and therapies (e.g. Malaysia, Brazil) Breast cancer integrated into broader health system; National Cancer Centre develops network with regional centres (India; Mexico, Cuba) Includes more advanced therapies, on-patent and costly therapies supply is limited (Malaysia; Brazil)
Maximal Comprehensive cancer plans with targets and metrics NHI covers full range of cancers and therapies, subject to national clinical guidelines (e.g. Uruguay) Includes organized mammographic screening, diagnosis and multidisciplinary treatment (e.g. Uruguay) Full range of therapies including those on-patent, as determined by national health technology assessments